Back to Search
Start Over
The addition of rituximab reduces the incidence of secondary central nervous system involvement in patients with diffuse large B-cell lymphoma.
- Source :
-
British journal of haematology [Br J Haematol] 2012 May; Vol. 157 (3), pp. 401-3. Date of Electronic Publication: 2012 Jan 09. - Publication Year :
- 2012
- Subjects :
- Adolescent
Adult
Aged
Aged, 80 and over
Drug Evaluation methods
Female
Humans
Male
Middle Aged
Retrospective Studies
Rituximab
Treatment Outcome
Young Adult
Antibodies, Monoclonal, Murine-Derived administration & dosage
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Central Nervous System Neoplasms prevention & control
Lymphoma, Large B-Cell, Diffuse drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1365-2141
- Volume :
- 157
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- British journal of haematology
- Publication Type :
- Editorial & Opinion
- Accession number :
- 22224728
- Full Text :
- https://doi.org/10.1111/j.1365-2141.2011.08998.x